hearing<\/strong> before the Controller<\/p>\n\n\n\nThe 12-month window is generous, but given the complexity of drafting a technically and legally sound response, it is advisable to begin work on the reply as early as possible after receiving the FER.<\/p>\n\n\n\n
\n\n\n\nCommon Grounds of Objection in the First Examination Report<\/h2>\n\n\n\n
Understanding the types of objections that are typically raised in an FER helps applicants and their patent agents prepare more effective responses. The most common grounds of objection in India include:<\/p>\n\n\n\n
1. Lack of Novelty (Section 2(1)(l) and Section 25)<\/h3>\n\n\n\n
\ud83d\udccb The Examiner cites prior art documents that disclose every element of one or more claims \ud83d\udccb If prior art discloses all the features of a claim, the claim lacks novelty and cannot be granted as filed \ud83d\udccb The response must either distinguish the claims from the cited prior art through argument, or amend the claims to add features not disclosed in the prior art<\/p>\n\n\n\n
2. Lack of Inventive Step (Obviousness) (Section 2(1)(ja))<\/h3>\n\n\n\n
\ud83d\udccb The Examiner argues that even if the claimed invention is not disclosed in a single prior art document, it would have been obvious to a person skilled in the relevant field to arrive at the invention by combining two or more prior art documents \ud83d\udccb Obviousness is the most commonly raised and most contested objection in Indian patent prosecution \ud83d\udccb The response must argue why the combination of prior art would not have been obvious, or amend the claims to distinguish from the combined prior art<\/p>\n\n\n\n
3. Non-Patentable Subject Matter (Section 3)<\/h3>\n\n\n\n
\ud83d\udccb Section 3 of the Patents Act, 1970 lists categories of inventions that are not patentable in India, regardless of novelty or inventive step \ud83d\udccb Common Section 3 objections include: \ud83d\udccb Section 3(d): A new form of a known substance that does not result in enhanced efficacy (particularly relevant in pharmaceutical applications) \ud83d\udccb Section 3(k): Mathematical methods, business methods, computer programmes per se, and algorithms (particularly relevant in software and technology applications) \ud83d\udccb Section 3(i): Methods of treatment of human beings or animals \ud83d\udccb Section 3(j): Plants, animals, and biological processes for their production \ud83d\udccb Section 3(p): Traditional knowledge \ud83d\udccb Responding to Section 3 objections requires careful legal and technical argumentation, particularly for pharmaceutical and software patent applications where these objections are most frequently raised<\/p>\n\n\n\n
4. Insufficient Disclosure (Section 10)<\/h3>\n\n\n\n
\ud83d\udccb The specification must disclose the invention in a manner sufficiently clear and complete for a person skilled in the art to perform it \ud83d\udccb If the Examiner finds that the disclosure is insufficient, the applicant must amend the specification to provide adequate enabling disclosure \ud83d\udccb The best mode of carrying out the invention must be disclosed<\/p>\n\n\n\n
5. Claim Drafting Issues<\/h3>\n\n\n\n
\ud83d\udccb Claims must be clear, concise, and fully supported by the description \ud83d\udccb Common claim drafting objections include: \ud83d\udccb Claims broader than the disclosure in the specification \ud83d\udccb Unclear claim language or undefined terms \ud83d\udccb Dependent claims that do not properly refer to or limit the independent claim \ud83d\udccb Multiple independent claims in the same category without justification<\/p>\n\n\n\n
6. Unity of Invention (Section 10(5) and Rule 13)<\/h3>\n\n\n\n
\ud83d\udccb A patent application must relate to a single invention or a group of inventions so linked as to form a single inventive concept \ud83d\udccb If the Examiner finds that the application contains claims to multiple distinct inventions, they may object on grounds of lack of unity \ud83d\udccb The applicant must either restrict the claims to a single invention or divide the application into separate divisional applications<\/p>\n\n\n\n
7. Formal Objections<\/h3>\n\n\n\n
\ud83d\udccb Issues with the format or completeness of the specification, drawings, abstract, or claims \ud83d\udccb Missing information in the application form \ud83d\udccb Issues with the priority claim or priority documents \ud83d\udccb Requirement for a sequence listing for biological sequence data<\/p>\n\n\n\n
\n\n\n\nStructure of an Effective Patent Objection Reply<\/h2>\n\n\n\n
A well-structured patent objection reply addresses every objection raised in the FER systematically and persuasively. The typical structure of a reply is:<\/p>\n\n\n\n
1. Introductory Section<\/h3>\n\n\n\n
\ud83d\udccb Reference to the FER (application number, date of FER) \ud83d\udccb Brief overview of the invention and its technical field \ud83d\udccb Statement that the applicant respectfully submits the following response to the objections raised in the FER<\/p>\n\n\n\n
2. Amendments to the Claims (if applicable)<\/h3>\n\n\n\n
\ud83d\udccb If the claims are being amended to address novelty, inventive step, or clarity objections, the amended claims are presented first \ud83d\udccb Amended claims should be presented in a clean version (showing the final amended text) and, where required, in a marked-up version showing the changes from the original claims \ud83d\udccb Amendments must not introduce new matter (subject matter not disclosed in the original specification as filed)<\/p>\n\n\n\n
3. Amendments to the Specification or Drawings (if applicable)<\/h3>\n\n\n\n
\ud83d\udccb If the specification or drawings are being amended to address insufficiency or formal objections, the amendments are presented with clear identification of the changes \ud83d\udccb Amendments to the specification must be based on matter already disclosed in the original application<\/p>\n\n\n\n
4. Response to Each Objection<\/h3>\n\n\n\n
\ud83d\udccb Each objection raised in the FER is addressed separately and in sequence \ud83d\udccb For each objection: \ud83d\udccb The objection is restated or summarised \ud83d\udccb Arguments in response are presented clearly and in detail \ud83d\udccb Relevant case law from Indian courts and the Intellectual Property Appellate Board (IPAB) is cited where applicable \ud83d\udccb Technical evidence (affidavits, experimental data, expert opinions) is submitted where appropriate \ud83d\udccb The applicant explains how the amended claims (if any) address the objection<\/p>\n\n\n\n
5. Conclusion<\/h3>\n\n\n\n
\ud83d\udccb A summary statement that all objections have been addressed \ud83d\udccb A request that the application be found in order for grant<\/p>\n\n\n\n
\n\n\n\nTips for a Successful Patent Objection Reply<\/h2>\n\n\n\nTip 1: Respond to Every Objection Without Exception<\/h3>\n\n\n\n
The most fundamental rule of patent prosecution is that every objection in the FER must be addressed in the response. Leaving an objection unaddressed, even one that seems minor, gives the Examiner grounds to maintain the objection and potentially refuse the application. Address each objection specifically and substantively.<\/p>\n\n\n\n
Tip 2: Understand the Prior Art Before Amending Claims<\/h3>\n\n\n\n
Before amending claims or making arguments to distinguish from cited prior art, read the cited documents carefully and completely. Do not rely on the Examiner’s summary of the prior art. The relevant disclosure in a cited document may be narrower than the Examiner suggests, or it may be broader. Understanding exactly what the prior art discloses is essential to framing effective arguments and amendments.<\/p>\n\n\n\n
Tip 3: Draft Claim Amendments That Are as Broad as Possible While Being Allowable<\/h3>\n\n\n\n
The goal of claim amendment is to define the invention in terms that are patentable over the prior art while retaining as much commercial scope as possible. Amendments that are unnecessarily narrow, limiting the claims to a specific embodiment when a broader formulation would be patentable, give away commercial protection that need not be surrendered. Work with your patent agent to identify the broadest defensible claim scope.<\/p>\n\n\n\n
Tip 4: Never Introduce New Matter<\/h3>\n\n\n\n
Amendments to the claims or specification must be supported by the original disclosure. Adding new matter, subject matter that was not disclosed in the application as originally filed, is a serious error that can result in the amended claims being rejected or, in the worst case, the patent being invalidated after grant. Every amendment must be traceable to the original specification.<\/p>\n\n\n\n
Tip 5: Use Strong Technical Arguments for Inventive Step<\/h3>\n\n\n\n
Inventive step objections are best addressed through a combination of technical argument and claim amendment. Effective technical arguments explain why a person skilled in the art would not have been motivated to combine the cited prior art documents, why the cited documents teach away from the claimed invention, or why the claimed combination produces unexpected results or advantages. Avoid generic arguments that do not engage specifically with the cited prior art.<\/p>\n\n\n\n
Tip 6: Address Section 3 Objections with Precision<\/h3>\n\n\n\n
Section 3 objections, particularly Section 3(d) for pharmaceuticals and Section 3(k) for software and business methods, require carefully constructed legal and technical arguments. For Section 3(d) objections, experimental data demonstrating enhanced efficacy of the new form compared to the known substance is typically necessary. For Section 3(k) objections, arguments should focus on the technical character of the invention and its technical effect beyond the computer programme itself. These are specialised arguments that require deep expertise in both the law and the technology.<\/p>\n\n\n\n
Tip 7: Support Arguments with Evidence Where Appropriate<\/h3>\n\n\n\n
Written arguments are often strengthened by supporting evidence. Evidence that can be submitted with the patent reply includes:<\/p>\n\n\n\n
\ud83d\udccb Experimental data:<\/strong> Laboratory results, clinical trial data, or performance comparisons demonstrating the technical advantages of the invention \ud83d\udccb Expert affidavits:<\/strong> Sworn statements from persons skilled in the relevant field supporting the arguments made in the reply \ud83d\udccb Comparative examples:<\/strong> Data comparing the claimed invention with the prior art to demonstrate superior performance \ud83d\udccb Commercial evidence:<\/strong> Evidence of commercial success or long-felt need (in some cases relevant to inventive step)<\/p>\n\n\n\nEvidence submitted with the reply is considered by the Examiner and can be decisive in resolving inventive step and Section 3 objections.<\/p>\n\n\n\n
Tip 8: Cite Relevant Indian and International Precedents<\/h3>\n\n\n\n
Indian patent law has a growing body of case law from the courts and the Intellectual Property Appellate Board (IPAB) that guides the interpretation of patentability requirements, particularly for Section 3 objections and inventive step. Citing relevant precedents strengthens the legal argument in the reply. Patent decisions from foreign jurisdictions (the EPO, USPTO, UK IPO) on similar inventions can also be persuasive, though they are not binding.<\/p>\n\n\n\n
Tip 9: Request a Hearing if the Written Reply Is Insufficient<\/h3>\n\n\n\n
If the objections are complex or the Examiner is unlikely to be persuaded by written arguments alone, or if a second examination report is issued maintaining the objections after the first reply, the applicant should request a hearing<\/strong> before the Controller. The hearing provides an opportunity to present oral arguments directly to the Controller, answer questions, and make real-time adjustments to the arguments. Many patents that would otherwise be refused are granted after a hearing where the applicant’s patent agent can engage directly with the Controller’s concerns.<\/p>\n\n\n\nTip 10: Work with an Experienced Patent Agent<\/h3>\n\n\n\n
Patent prosecution in India is a specialised discipline. The Patents Act, 1970, the Patents Rules, 2003, and the examination guidelines require detailed knowledge. An experienced patent agent, particularly one with expertise in the relevant technology field, can significantly improve the quality of the reply and the probability of grant. The cost of professional patent prosecution is small relative to the value of the patent if granted.<\/p>\n\n\n\n
\n\n\n\nWhat Happens After the Reply Is Filed<\/h2>\n\n\n\n
After the applicant files the reply to the FER, one of the following outcomes typically follows:<\/p>\n\n\n\n
Outcome 1: Second Examination Report<\/h3>\n\n\n\n
\ud83d\udccb The Examiner may issue a Second Examination Report<\/strong> (also called a Hearing Notice in some cases) if they are not satisfied that all objections have been addressed \ud83d\udccb The second report may maintain some or all of the original objections, raise new objections based on the amendments made, or indicate that the Controller is minded to refuse the application \ud83d\udccb The applicant has the right to respond to the second report and\/or request a hearing<\/p>\n\n\n\nOutcome 2: Hearing Notice<\/h3>\n\n\n\n
\ud83d\udccb If the Controller is not satisfied with the written response and is considering refusal, a Hearing Notice<\/strong> is issued under Rule 129 of the Patents Rules, 2003 \ud83d\udccb The hearing notice informs the applicant of the date and time of the hearing before the Controller \ud83d\udccb The applicant (through their patent agent) attends the hearing and presents oral arguments \ud83d\udccb After the hearing, the Controller issues a decision either granting or refusing the patent<\/p>\n\n\n\nOutcome 3: Grant of Patent<\/h3>\n\n\n\n
\ud83d\udccb If the Examiner is satisfied that all objections have been addressed through the written reply and any amendments, the application is accepted and the patent is granted<\/strong> \ud83d\udccb A Letter Patent (patent grant certificate) is issued to the applicant \ud83d\udccb The granted patent is published in the Patent Office Journal \ud83d\udccb The patent is valid for 20 years<\/strong> from the date of filing of the application, subject to payment of annual renewal fees<\/p>\n\n\n\nOutcome 4: Refusal<\/h3>\n\n\n\n
\ud83d\udccb If the Controller is not satisfied that the objections have been addressed after the written reply and hearing (if any), the patent application is refused<\/strong> \ud83d\udccb The applicant has the right to appeal<\/strong> the refusal to the High Court under Section 117A of the Patents Act, 1970 \ud83d\udccb Appeals from patent refusals are heard by the High Court having territorial jurisdiction over the relevant Patent Office<\/p>\n\n\n\n
\n\n\n\nPatent Maintenance After Grant: Annual Renewal Fees<\/h2>\n\n\n\n
Once a patent is granted, it must be maintained by paying annual renewal fees<\/strong> to the Indian Patent Office:<\/p>\n\n\n\n\ud83d\udccb Renewal fees are payable from the third year<\/strong> of the patent (calculated from the date of filing) \ud83d\udccb Renewal fees increase progressively each year \ud83d\udccb Failure to pay the renewal fee results in the patent lapsing \ud83d\udccb A lapsed patent can be restored within 18 months of lapse upon payment of the renewal fee and a restoration fee, subject to the Controller’s satisfaction that the lapse was unintentional<\/p>\n\n\n\n
\n\n\n\nCommon Mistakes in Patent Objection Replies<\/h2>\n\n\n\n
Failing to address all objections:<\/strong> Every objection in the FER must be addressed. A reply that ignores even a minor formal objection gives the Examiner grounds to issue a further report or refuse the application.<\/p>\n\n\n\nMaking amendments that introduce new matter:<\/strong> Amendments must be supported by the original disclosure. New matter added through amendments is a ground for refusal and, if the patent is granted, can be a ground for post-grant opposition or invalidation.<\/p>\n\n\n\nMaking claims unnecessarily narrow:<\/strong> Over-limiting claims to secure grant sacrifices commercial protection that need not be surrendered. Always seek the broadest defensible claim scope consistent with patentability over the prior art.<\/p>\n\n\n\nSubmitting generic arguments for inventive step:<\/strong> Arguments that the claimed invention is inventive without engaging specifically with the cited prior art are rarely persuasive. Address the specific prior art combinations cited by the Examiner with specific technical arguments.<\/p>\n\n\n\nMissing the 12-month response deadline:<\/strong> Missing the statutory deadline results in automatic abandonment of the application. There is no extension of time and no relief available after abandonment in most cases. Diarise the response deadline immediately upon receiving the FER.<\/p>\n\n\n\nNot requesting a hearing when needed:<\/strong> Many applicants file a written reply and, when it is not fully successful, allow the application to lapse or be refused without requesting a hearing. The hearing is a valuable procedural right that should be used whenever the written reply alone is unlikely to resolve the outstanding objections.<\/p>\n\n\n\n
\n\n\n\n
![\"patent-objection-reply\"](\"http:\/\/quickstartupindia.com\/blog\/wp-content\/uploads\/2026\/05\/patent-objection-reply-1024x768.png\" "\\"\\"")